Nicotine pouches are not harmless. They deliver a potent, addictive stimulant that raises heart rate, constricts blood vessels, and can damage your gums over time. That said, they contain far fewer toxic compounds than cigarettes or traditional chewing tobacco, which makes the real answer more nuanced than a simple yes or no. The health risks depend heavily on whether you’re using them as an alternative to smoking or picking them up as a new habit.
What’s Actually Inside a Nicotine Pouch
Unlike traditional snus or chewing tobacco, nicotine pouches contain no tobacco leaf. Most brands use a cellulose-based filler (about 80% of products on the market) as the base material that sits against your gum. The nicotine itself comes in different forms depending on the brand. ZYN uses a nicotine salt called nicotine bitartrate dihydrate, while brands like LUCY and Rogue use nicotine polacrilex, the same resin-bound nicotine found in nicotine gum.
Nearly all manufacturers add sodium bicarbonate or sodium carbonate to raise the pH of the pouch. This isn’t just for comfort. A higher pH helps nicotine cross through your gum tissue and into your bloodstream faster, producing a stronger and quicker hit. Artificial sweeteners like acesulfame potassium and sucralose round out the ingredient list, along with flavoring chemicals. Menthol is the most common, found in 60% of products, followed by menthone and benzyl alcohol.
Pouch strengths typically range from 3 to 15 mg of nicotine, though some products contain as much as 50 mg per pouch. For comparison, a single cigarette contains about 10 to 12 mg of nicotine. So a high-strength pouch can deliver several times the nicotine of a cigarette in a single use.
How Nicotine Affects Your Heart
The American Heart Association has been blunt: no long-term cardiovascular data exists specifically for nicotine pouches, and the absence of data does not mean they’re safe. What is well understood is what nicotine itself does to your cardiovascular system regardless of the delivery method. It acutely raises heart rate and blood pressure, constricts blood vessels (including diseased coronary arteries), reduces heart rate variability, and increases arterial stiffness.
Research on smokeless tobacco products in general shows that a single use raises blood pressure by 5 to 10 mm Hg, while daily users see a smaller but persistent average increase of under 5 mm Hg. There is one potential upside compared to smoking: because nicotine absorbs more slowly through the gum lining than through the lungs, the cardiovascular spike may be less pronounced. But “less pronounced” is not the same as absent, especially with habitual use throughout the day.
Nicotine and Insulin Resistance
One underappreciated risk of chronic nicotine use, through any delivery system, is its effect on blood sugar regulation. A study comparing long-term nicotine gum users to matched controls found that sustained nicotine exposure was associated with insulin resistance and elevated insulin levels, even in healthy, nonobese men. The degree of insulin resistance correlated directly with how much nicotine people were consuming, measured by cotinine (a nicotine byproduct) in their blood. This suggests nicotine itself, not the tar or carbon monoxide from cigarettes, is a key driver of the metabolic problems long associated with smoking.
Gum Damage and Oral Health
This is where nicotine pouches cause their most visible harm. Placing a pouch against the same spot on your gum repeatedly exposes that tissue to concentrated nicotine and alkaline chemicals designed to speed absorption. Over time, this can erode gum tissue in that specific area.
Dentists are already seeing the consequences. One dentist in the UK who has spent two years researching nicotine pouch effects reports treating patients with gum lesions deep enough to expose the tooth root. He notes an increased risk of localized gum disease and localized bone loss in users. In Sweden, where nicotine pouch use is more established, 25% of people aged 16 to 29 use these products, and dentists report growing numbers of patients with painful gum inflammation that takes months or even years to heal.
Users themselves describe severe irritation with heavy use. Reports of gums being “shredded” or tissue peeling away are not uncommon, particularly among people using multiple pouches a day or placing them in the same spot consistently. If you do use pouches, rotating the placement site can reduce concentrated damage to a single area.
Cancer Risk Compared to Cigarettes
One of the strongest arguments in favor of nicotine pouches is their dramatically lower levels of cancer-causing compounds. Tobacco-specific nitrosamines (TSNAs), the carcinogens most associated with tobacco products, are present in nicotine pouches but at trace levels. The highest amounts detected in pouches were about 12.9 nanograms of NNN and 5.4 nanograms of NNK per pouch.
To put those numbers in context: traditional spit-free snus contains up to 1,190 ng of NNN per pouch, roughly 90 times more. Cigarette smoke delivers 33 to 323 ng of NNN and 40 to 246 ng of NNK per cigarette. Even nicotine gum, a pharmaceutical product, has been found to contain about 2 ng of NNN per gram. So while nicotine pouches are not carcinogen-free, their TSNA levels are a fraction of what you’d get from cigarettes, traditional smokeless tobacco, or even some nicotine replacement products.
Risks for Teenagers and Young Adults
Nicotine pouch use is rising significantly among U.S. teens, and this is where the health calculus shifts sharply. For an adult smoker switching to pouches, the trade-off may reduce overall harm. For a teenager who has never used tobacco, picking up nicotine pouches introduces a highly addictive substance during a critical window of brain development. Research indicates that adolescent nicotine exposure can harm the developing brain and cause lasting problems with learning, memory, and attention.
The flavors, discreet packaging, and lack of smoke or vapor make pouches easy to use undetected, which has accelerated uptake among young people. Many start casually and find themselves dependent quickly. Nicotine is one of the most addictive substances known, and pouches deliver it efficiently enough to establish dependence within weeks of regular use.
FDA Authorization Is Not a Safety Endorsement
As of late 2025, only certain ZYN and on! PLUS products have received FDA marketing authorization. These are limited to lower-strength options (3, 6, and 9 mg) in specific flavors. Every other nicotine pouch on the U.S. market is technically being sold without authorization.
The FDA has been explicit that authorization does not mean approval or safety. The agency’s own language states: “All tobacco products are harmful and potentially addictive. Those who do not use tobacco products shouldn’t start.” Authorization simply means the FDA determined that allowing these specific products on the market is, on balance, appropriate for public health, likely because they offer existing smokers a less harmful alternative.
The Bottom Line on Harm
Nicotine pouches sit in a gray zone. They contain far fewer toxicants than cigarettes, carry dramatically lower carcinogen levels than any combustible tobacco product, and eliminate the lung damage associated with smoking or vaping. For someone currently smoking a pack a day, switching to pouches would almost certainly reduce their health risk.
But they are not risk-free. They deliver enough nicotine to raise blood pressure, promote insulin resistance, damage gum tissue, and create strong physical dependence. The long-term cardiovascular consequences remain unknown simply because these products haven’t existed long enough to study. If you don’t currently use nicotine in any form, starting with pouches means taking on all of these risks for no health benefit at all.